W
Research Areas
Biography and Research Information
OverviewAI-generated summary
William T. Atchley's research focuses on pulmonary diseases, particularly chronic obstructive pulmonary disease (COPD) and its relationship with aging. His work also examines specific conditions like pulmonary hypertension in COPD and interstitial lung disease, investigating potential treatments such as inhaled nitric oxide. Atchley has also published on immune checkpoint inhibitor-related pneumonitis in lung cancer and the association of tocilizumab with fungal infections in critically ill COVID-19 patients.
His publications include studies on the pathophysiology and care of aging populations with COPD, as well as the interrelationships between aging and COPD. Atchley's scholarship metrics include an h-index of 7, with 16 total publications and 429 total citations. He has collaborated with several colleagues at the University of Arkansas for Medical Sciences, including Nikhil Meena, Rajani Jagana, Sarenthia M. Epps, and Barrett J. Burger, each with whom he shares three publications.
Metrics
- h-index: 7
- Publications: 16
- Citations: 435
Selected Publications
-
Navigating COPD in Aging Populations: Insights Into Pathophysiology and Comprehensive Care (2024)
-
Vasoreactivity in Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension - A Case of Robust Response to Inhaled Nitric Oxide (iNO) (2024)
-
Pulmonary hypertension in chronic obstructive pulmonary disease: current understanding, knowledge gaps and future directions (2023)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)
-
Ageing and chronic obstructive pulmonary disease: interrelationships (2023)
-
Response (2022)
-
Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021)
-
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer (2021)
Grants & Funding
Collaboration Network
Top Collaborators
Barrett J. Burger
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Sarenthia M. Epps
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Víctor M. Cárdenas
University of Arkansas for Medical Sciences (US)
3 shared publications
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Nikhil Meena
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Rajani Jagana
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Carolina Álvarez
2 shared publications
- Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
- Response
Shruti Saxena
2 shared publications
- Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
- Response
Todd A. Schwartz
2 shared publications
- Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
- Response
Rumey C. Ishizawar
2 shared publications
- Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
- Response
Kunal P. Patel
University of North Carolina at Chapel Hill (US)
2 shared publications
- Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
- Response
M. Patricia Rivera
University of North Carolina at Chapel Hill (US)
2 shared publications
- Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
- Response
Shannon K. Brewer
University of Arkansas for Medical Sciences
2 shared publications
In database
- Navigating COPD in Aging Populations: Insights Into Pathophysiology and Comprehensive Care
- Vasoreactivity in Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension - A Case of Robust Response to Inhaled Nitric Oxide (iNO)
Krishna Kakkera
Pulmonary and Critical Care Associates
1 shared publication
In database
- Ageing and chronic obstructive pulmonary disease: interrelationships
Maneetha Kodali
University of Arkansas for Medical Sciences
1 shared publication
In database
- Ageing and chronic obstructive pulmonary disease: interrelationships
Thaddeus Bartter
University of Arkansas for Medical Sciences
1 shared publication
In database
- Ageing and chronic obstructive pulmonary disease: interrelationships
Similar Researchers
Based on overlapping research topics
Thaddeus Bartter
University of Arkansas for Medical Sciences
Chronic Obstructive Pulmonary Disease (COPD) Research
Geriatric Care and Nursing Homes
COVID-19 Clinical Research Studies
Krishna Kakkera
University of Arkansas for Medical Sciences
Chronic Obstructive Pulmonary Disease (COPD) Research
Geriatric Care and Nursing Homes
Immune Response and Inflammation
Anand N. Venkata
University of Arkansas for Medical Sciences
Chronic Obstructive Pulmonary Disease (COPD) Research
COVID-19 Clinical Research Studies
Lung Cancer Diagnosis and Treatment
Sajjad A. Bhatti
University of Arkansas for Medical Sciences
Geriatric Care and Nursing Homes
Immune Response and Inflammation
Lung Cancer Diagnosis and Treatment
Benjamin M Boral
University of Arkansas at Fayetteville
Immune Response and Inflammation
COVID-19 Clinical Research Studies
Cardiovascular Function and Risk Factors
Neelesh Gupta
University of Arkansas for Medical Sciences
Geriatric Care and Nursing Homes
COVID-19 Clinical Research Studies
Cardiovascular Function and Risk Factors